Safeguard your patients with an efficacious therapy. Quality Inspire Confidence
Nosocomial pneumonia
(HAP/ VAP).
Complicated UTI.
Intra-abdominal infections.
Empiric treatment for febrile neutropenia.
Bacterial septicemia.
Bacterial meningitis.
Complicated skin and
soft tissue infections.
87%-91% clinical response rates at end of treatment & 96%-100% at follow up in community acquired pneumonia.
93%-100% effective for UTI.
93% effective for lower respiratory tract infections.
80% clinical success rate in polymicrobial intra-abdominal infections.
84% clinical cure rates
against serious bacterial infections.
Nosocomial pneumonia
(HAP/ VAP).
Complicated UTI.
Intra-abdominal infections.
Empiric treatment for febrile neutropenia.
Bacterial septicemia.
Bacterial meningitis.
Complicated skin and
soft tissue infections.
87%-91% clinical response rates at end of treatment & 96%-100% at follow up in community acquired pneumonia.
93%-100% effective for UTI.
93% effective for lower respiratory tract infections.
80% clinical success rate in polymicrobial intra-abdominal infections.
84% clinical cure rates
against serious bacterial infections. Sales
Sales
Sales